Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aleafia Health Inc ALEAF

Aleafia Health Inc. is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets. The Company is engaged in the production, sale, and distribution of cannabis. It operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across... see more

GREY:ALEAF - Post Discussion

Aleafia Health Inc > AH: UPDATE ON ITS CONVERTIBLE DEBT/AGRMNT EXTENDED TO MAR 14
View:
Post by Humanist on Mar 01, 2022 10:02pm

AH: UPDATE ON ITS CONVERTIBLE DEBT/AGRMNT EXTENDED TO MAR 14

Aleafia Health Provides Further Update on its Convertible Debt
    
by @nasdaq on 1 Mar 2022, 19:14
 
TORONTO, March 01, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022 (the “Convertible Debt”).

Further to the Company’s announcement on February 1, 2022, the Forbearance Agreement, entered into between the Company and holders of Convertible Debt representing approximately 58% of the aggregate principal amount of debentures outstanding, has been extended until March 14, 2022. The holders of Convertible Debt representing an additional 4% of the aggregate principal amount of debentures outstanding have subsequently entered into the Forbearance Agreement. The Agreement automatically renews for 14-day periods thereafter unless advance notice to the contrary is provided.

The parties have continued to work expeditiously and in good faith to negotiate a potential transaction to amend the terms associated with the Convertible Debt.

For Investor & Media Relations:
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com
Comment by Highandlows on Mar 04, 2022 8:11pm
This post has been removed in accordance with Community Policy
Comment by Humanist on Mar 09, 2022 10:35am
Just a reminder that we have until monday to hear about the convertible debt!!  as per my prev post below
Comment by IMB on Mar 09, 2022 12:16pm
It will get automatically renewd with a press release stated that.
Comment by Toweringmars on Mar 09, 2022 12:56pm
IMB You've got mail.
Comment by IMB on Mar 09, 2022 2:32pm
I replied to you.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities